Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BSH BTC + Utooth BTC is a combination therapy consisting of two preparations of allogeneic human dental pulp stem cells. These stem cells are harvested from the dental pulp of extracted wisdom teeth from adult donors. The product is being investigated for its regenerative and therapeutic potential, likely leveraging the multipotency and immunomodulatory properties of dental pulp-derived mesenchymal stem cells. The primary indications under investigation include various conditions where tissue regeneration or immune modulation may be beneficial[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on BSH BTC + Utooth BTC.